Canada· CA-DIN-02312557

BOOSTRIX-POLIO

A diphtherie-pertussis-poliomyelitis-tetanus product containing diphtheria toxoid adsorbed + pertactin adsorbed + tetanus toxoid adsorbed + filamentous haemagglutinin adsorbed, registered in Canada by GLAXOSMITHKLINE INC. The same ATC class is registered in 11 of our 19 countries.

ATC J07CA02

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedBOOSTRIX-POLIOATCJ07CA02REGISTER NO.CA-DIN-02312557PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Diphtherie-pertussis-poliomyelitis-tetanus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07CA02 (diphtherie-pertussis-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose

Diphtherie-pertussis-poliomyelitis-tetanus · ATC J07CA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
DIPHTHERIA TOXOID ADSORBED + PERTACTIN ADSORBED + TETANUS TOXOID ADSORBED + FILAMENTOUS HAEMAGGLUTININ ADSORBED
Manufacturer
GLAXOSMITHKLINE INC
Country
Canada (CA)
ATC code
J07CA02
ATC class
Diphtherie-Pertussis-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d84401a4-c416-4633-8220-16e15f5244ea
GET /v1/drugs/d84401a4-c416-4633-8220-16e15f5244ea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02312557",
  "form": "SUSPENSION",
  "class": "Human",
  "routes": [
    "INTRAMUSCULAR"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J07CA02",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "79806",
  "strengths": [
    "2.5 LF",
    "2.5 MCG",
    "5.0 LF",
    "8 MCG",
    "8 D",
    "32 D",
    "40 D"
  ],
  "ahfs_class": null,
  "substances": [
    "DIPHTHERIA TOXOID ADSORBED",
    "PERTACTIN ADSORBED",
    "TETANUS TOXOID ADSORBED",
    "FILAMENTOUS HAEMAGGLUTININ ADSORBED",
    "INACTIVATED POLIOVIRUS TYPE II",
    "INACTIVATED POLIOVIRUS TYPE III",
    "PERTUSSIS TOXOID ADSORBED",
    "INACTIVATED POLIOVIRUS TYPE I"
  ],
  "product_categorization": null
}

See everything about diphtherie-pertussis-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.